Simplex Trading’s CollPlant Biotechnologies CLGN Stock Holding History

Simplex Trading’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12	Closed	-$63	–	9389
2026 Q1	$63	Buy	+12	New	+$121	﹤0.01%	8892
2025 Q4	–	Sell	-9	Closed	–	–	8717
2025 Q3	$0	Hold	9	–	–	﹤0.01%	9163
2025 Q2	$0	Buy	+9	New	+$186	﹤0.01%	8753
2023 Q4	–	Sell	-10	Closed	–	–	8886
2023 Q3	$0	Buy	+10	New	+$662	﹤0.01%	8769
2022 Q4	–	Sell	-59	Closed	-$3K	–	9315
2022 Q3	$3K	Buy	+59	New	+$4.79K	﹤0.01%	9052
2022 Q2	–	Sell	-83	Closed	-$7.58K	–	10058
2022 Q1	$9K	Sell	83 -78	-48%	-$8.57K	﹤0.01%	8943
2021 Q4	$26K	Buy	+161	New	+$28.7K	﹤0.01%	8070

Other funds holding CLGN

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

LWMI

Legacy Wealth Management (Idaho) Boise, Idaho $243M AUM 8.27% 1-Year Est. Return

WPC

Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Simplex Trading's CLGN Position: Q2 2026 in Review

Simplex Trading sold out of CollPlant Biotechnologies (CLGN) in Q2 2026, closing a stake of 12 shares — an estimated $63 sold.

Simplex Trading first reported a position in CLGN in Q4 2021 and held it in 7 quarters. The position peaked at $26K in Q4 2021. 15 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

Simplex Trading reported no remaining CollPlant Biotechnologies position as of Q2 2026 after selling out during the quarter.
Simplex Trading sold 12 CollPlant Biotechnologies shares in Q2 2026, an estimated $63.
Simplex Trading first reported a position in CollPlant Biotechnologies in Q4 2021 and held it in 7 quarters.
Simplex Trading's CollPlant Biotechnologies position peaked at $26K in Q4 2021.
15 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.